Technology ❯Biotechnology

mRNA Technology

mRNA Technology Covid-19 Genetic Engineering Genetics Mergers and Acquisitions HIV Disease Prevention Artificial Intelligence Pharmaceuticals Economic Development

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Approved by both companies’ boards, the all-stock acquisition is slated to close in 2025 pending regulatory approval.

Scientists Use mRNA to Expose Hidden HIV in White Blood Cells

UK Finalizes £1bn BioNTech Deal to Advance mRNA Cancer Vaccines and AI Research

Sanofi Announces $20 Billion U.S. Investment to Expand Manufacturing and R&D